ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease-Reference-Cited by-同舟云学术

ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease

Published:2017-11-27 Issue:3 Volume:118 Page:1092-1136
ISSN:0009-2665
Container-title:Chemical Reviews
language:en
Short-container-title:Chem. Rev.

Author:

Lüscher Bernhard¹^ORCID,Bütepage Mareike¹,Eckei Laura¹,Krieg Sarah¹^ORCID,Verheugd Patricia¹,Shilton Brian H.¹²

Affiliation:

1. Institute of Biochemistry and Molecular Biology, Medical School, RWTH Aachen University, 52057 Aachen, Germany

2. Department of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, Medical Sciences Building Room 332, London, Ontario Canada N6A 5C1

Funder

RWTH Aachen University

Deutsche Forschungsgemeinschaft

Natural Sciences and Engineering Research Council of Canada

Faculty of Medicine, RWTH Aachen University

Aachen Interdisciplinary Center for Clinical Research, RWTH Aachen University

Publisher

American Chemical Society (ACS)

Subject

General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.chemrev.7b00122

Reference543 articles.

1. Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry

2. Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development

3. PARP inhibitor combination therapy

4. PARP inhibitors for anticancer therapy

5. An update on PARP inhibitors—moving to the adjuvant setting

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly‐ADP‐ribosylation dynamics, signaling, and analysis;Environmental and Molecular Mutagenesis;2024-09-02

2. Posttranslational modifications of E2F family members in the physiological state and in cancer: Roles, mechanisms and therapeutic targets;Biomedicine & Pharmacotherapy;2024-09

3. GATA factor TRPS1, a new DNA repair protein, cooperates with reversible PARylation to promote chemoresistance in breast cancer patients;Journal of Biological Chemistry;2024-09

4. Targeting selective inhibitors of PARPs in drug discovery and development;Medicinal Chemistry Research;2024-07-28

5. If the 5’ cap fits (wear it) – Non-canonical RNA capping;RNA Biology;2024-07-15